4Z6A image
Deposition Date 2015-04-04
Release Date 2015-12-30
Last Version Date 2024-01-10
Entry Detail
PDB ID:
4Z6A
Keywords:
Title:
Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.25 Å
R-Value Free:
0.24
R-Value Work:
0.18
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Coagulation factor VII
Gene (Uniprot):F7
Mutations:[169-175] LQQSRKVGDSPN - EASYPGK
Chain IDs:B (auth: H)
Chain Length:249
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Coagulation factor VII
Gene (Uniprot):F7
Chain IDs:A (auth: L)
Chain Length:96
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Tissue factor
Gene (Uniprot):F3
Chain IDs:C (auth: T)
Chain Length:207
Number of Molecules:1
Biological Source:Homo sapiens
Peptide-like Molecules
PRD_000369
Primary Citation
Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity.
J.Biol.Chem. 291 4671 4683 (2016)
PMID: 26694616 DOI: 10.1074/jbc.M115.698613

Abstact

The complex of coagulation factor VIIa (FVIIa), a trypsin-like serine protease, and membrane-bound tissue factor (TF) initiates blood coagulation upon vascular injury. Binding of TF to FVIIa promotes allosteric conformational changes in the FVIIa protease domain and improves its catalytic properties. Extensive studies have revealed two putative pathways for this allosteric communication. Here we provide further details of this allosteric communication by investigating FVIIa loop swap variants containing the 170 loop of trypsin that display TF-independent enhanced activity. Using x-ray crystallography, we show that the introduced 170 loop from trypsin directly interacts with the FVIIa active site, stabilizing segment 215-217 and activation loop 3, leading to enhanced activity. Molecular dynamics simulations and novel fluorescence quenching studies support that segment 215-217 conformation is pivotal to the enhanced activity of the FVIIa variants. We speculate that the allosteric regulation of FVIIa activity by TF binding follows a similar path in conjunction with protease domain N terminus insertion, suggesting a more complete molecular basis of TF-mediated allosteric enhancement of FVIIa activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures